Anna Bellmunt, PhD, is an Associate at Asabys Partners, where she is responsible for sourcing and assessing opportunities from the scientific, development and business perspectives.
Prior to joining Asabys Partners, Anna was Investment Analyst at LSP (Life Sciences Partners) where she was responsible for the initial deal flow screening and in-depth scientific and clinical due diligence on investment opportunities. Previously, she served as Innovation Manager at the Knowledge and Technology Transfer Office at Hospital Clínic de Barcelona and its Research Institute IDIBAPS where she was involved in the management of innovative healthcare projects. Her primary role was to advise entrepreneurs on intellectual property protection and commercialization strategies. Before, Anna was a researcher in the Growth Control and Cancer Metastasis group at the IRB Barcelona led by Prof. Roger Gomis. Her main research focused on mechanisms of metastasis resulting in several publications in leading scientific journals.
Anna was awarded a PhD in Biomedicine from the University of Barcelona (UB), a Master’s degree in Biomedical Research from the Pompeu Fabra University (UPF) and Anna holds two Bachelor’s degrees; in Chemistry and Biochemistry, by the University of Barcelona (UB). She combined her studies with scientific research training in several research groups in Paris and Barcelona.